
Sleuth provides biopharma teams fast, verifiable competitive intelligence to support strategic decisions and market analysis. The company combines AI and natural language processing with a proprietary structured database of 100M+ curated external data points—including clinical trials, patents, regulatory filings, and earnings transcripts—to automate recurring research and deliver presentation-ready reports. Offered as a B2B competitive intelligence platform with done-for-you research services and annual retainer licenses, Sleuth uses human-in-the-loop verification and does not train models on client data to preserve security and accuracy. The platform emphasizes global market coverage, including China, and targets biopharma leaders seeking ongoing monitoring and bespoke strategic analysis.

Sleuth provides biopharma teams fast, verifiable competitive intelligence to support strategic decisions and market analysis. The company combines AI and natural language processing with a proprietary structured database of 100M+ curated external data points—including clinical trials, patents, regulatory filings, and earnings transcripts—to automate recurring research and deliver presentation-ready reports. Offered as a B2B competitive intelligence platform with done-for-you research services and annual retainer licenses, Sleuth uses human-in-the-loop verification and does not train models on client data to preserve security and accuracy. The platform emphasizes global market coverage, including China, and targets biopharma leaders seeking ongoing monitoring and bespoke strategic analysis.
Industry: Biotechnology / Biopharma intelligence
Founded: 2023
Headquarters: Los Angeles, California
Product: AI-powered competitive intelligence platform + analyst services
Employees (approx.): 17
Commercial diligence, competitive intelligence, and market analysis for biopharma companies.
2023
Biotechnology
7684787
“Unpopular Ventures participated in a funding event dated 2025-10-16”